News Home

OptiNose Inc (OPTN) Stock: What Does the Chart Say Tuesday?

Tuesday, February 23, 2021 02:35 PM | InvestorsObserver Analysts
OptiNose Inc (OPTN) Stock: What Does the Chart Say Tuesday?

OptiNose Inc (OPTN) stock has fallen 10.75% over the past week and gets a Bearish rating from InvestorsObserver's Sentiment Indicator.

Sentiment Score - ,bearish
OptiNose Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on OPTN!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.

InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.

Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With OPTN Stock Today?

OptiNose Inc (OPTN) stock is trading at $4.07 as of 2:31 PM on Tuesday, Feb 23, a loss of -$0.07, or -1.69% from the previous closing price of $4.14. The stock has traded between $3.90 and $4.11 so far today. Volume today is 468,849 compared to average volume of 456,226.

To see InvestorsObserver's Sentiment Score for OptiNose Inc click here.

More About OptiNose Inc

OptiNose Inc is a US-based specialty pharmaceutical company which focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. The lead product of the company, XHANCE nasal spray, which utilizes proprietary breath powered exhalation delivery system, to deliver a topically-acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids. The pipeline products of the company include XHANCE, OPN-300, OPN-021, and AVP-825.

Click Here to get the full Stock Score Report on OptiNose Inc (OPTN) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App